RecruitingNCT06394089

Effect of Degenerative Spondylolisthesis on the Clinical Outcome of Unilateral Biportal Endoscopy for Lumbar Spinal Stenosis: Study Protocol

Effect of Degenerative Spondylolisthesis on the Clinical Outcome of Unilateral Biportal Endoscopy for Lumbar Spinal Stenosis: a Single-center, Prospective Cohort Trial Protocol


Sponsor

Beijing Friendship Hospital

Enrollment

150 participants

Start Date

Mar 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

A single-center, prospective cohort trial aims to provide stronger evidence regarding the impact of degenerative spondylolisthesis on the clinical outcome of unilateral biportal endoscopy for lumbar spinal stenosis


Eligibility

Min Age: 50 YearsMax Age: 80 Years

Inclusion Criteria5

  • Age range: 50-80 years
  • Diagnosis of LSS affecting 1-2 vertebral levels
  • Predominant manifestation of neurogenic intermittent claudication, with ineffective conservative treatment for at least 3 months
  • Presence of lumbar DS of less than grade II and absence of spine instability
  • Willingness to participate in the study and complete follow-up assessments.

Exclusion Criteria7

  • Diagnosis of isthmic lumbar spondylolisthesis or lumbar DS of grade ≥II
  • Evidence of instability at the affected vertebral level (intervertebral angle change \> 15° and/or vertebral translation ≥ 4.5 mm in standing flexion-extension radiographs of the lumbar spine)
  • History of prior surgery at the affected vertebral level
  • Presence of scoliosis with a Cobb angle \>20º
  • Presence of other conditions affecting the lumbar spine (infection, tumor, fracture, neurological diseases, and others)
  • Medical disorders that preclude surgical tolerance
  • Participation in other clinical research projects related to the treatment of lumbar spinal stenosis.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Beijing Friendship Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06394089


Related Trials